CIK 0001730430 · Large accelerated filer
Kiniksa Pharmaceuticals International, plc
Sign in to watch- Ticker
- KNSA
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Entity type
- operating
- EIN
- 981795578
- Phone
- 7814319100
- Business address
- 105 PICCADILLY, SECOND FLOOR, LONDON, United Kingdom, W1J 7NJ
- Former names
- Kiniksa Pharmaceuticals, Ltd.
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $78,588,440
- in 8 filings, $78.6M under 10b5-1 plans
Net −$78,588,440. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
- Patel Sanj K −$51.7M CHAIRMAN & CEO sold 42% of stake
- Moat Ross −$9.6M CHIEF OPERATING OFFICER sold 91% of stake
- Paolini John F. −$8.9M CHIEF MEDICAL OFFICER sold 58% of stake
- Megna Michael R −$4.9M CHIEF ACCOUNTING OFFICER sold 80% of stake
- Ragosa Mark −$3.4M CHIEF FINANCIAL OFFICER sold 64% of stake
Reading 59 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2023-04-10 | Ragosa Mark CHIEF FINANCIAL OFFICER | Option exercise · Restricted Share Unit | +2,695 | 8,082 | ||
| 2023-04-10 | Tessari Eben CHIEF OPERATING OFFICER | Option exercise | +2,727 | 120,868 | ||
| 2023-04-10 | Tessari Eben CHIEF OPERATING OFFICER | Shares withheld for taxes | −801 | $10.71 | $9K | 120,067 |
| 2023-04-10 | Tessari Eben CHIEF OPERATING OFFICER | Option exercise · Restricted Share Unit | +2,727 | 8,178 | ||
| 2023-04-01 | Moat Ross CHIEF COMMERCIAL OFFICER | Grant or award · Share Option | +38,668 | 38,668 | ||
| 2023-04-01 | Moat Ross CHIEF COMMERCIAL OFFICER | Grant or award · Restricted Share Unit | +6,445 | 6,445 | ||
| 2023-04-01 | Paolini John F. CHIEF MEDICAL OFFICER | Grant or award · Share Option | +38,974 | 38,974 | ||
| 2023-04-01 | Paolini John F. CHIEF MEDICAL OFFICER | Grant or award · Restricted Share Unit | +6,496 | 6,496 | ||
| 2023-04-01 | Megna Michael R CHIEF ACCOUNTING OFFICER | Grant or award · Share Option | +20,459 | 20,459 | ||
| 2023-04-01 | Megna Michael R CHIEF ACCOUNTING OFFICER | Grant or award · Restricted Share Unit | +10,230 | 10,230 | ||
| 2023-04-01 | Ragosa Mark CHIEF FINANCIAL OFFICER | Grant or award · Share Option | +42,050 | 42,050 | ||
| 2023-04-01 | Ragosa Mark CHIEF FINANCIAL OFFICER | Grant or award · Restricted Share Unit | +7,000 | 7,000 | ||
| 2023-04-01 | Tessari Eben CHIEF OPERATING OFFICER | Grant or award · Share Option | +42,544 | 42,544 | ||
| 2023-04-01 | Tessari Eben CHIEF OPERATING OFFICER | Grant or award · Restricted Share Unit | +7,091 | 7,091 | ||
| 2023-04-01 | Patel Sanj K CHAIRMAN & CEO | Grant or award · Share Option | +155,500 | 155,500 | ||
| 2023-04-01 | Patel Sanj K CHAIRMAN & CEO | Grant or award · Restricted Share Unit | +25,925 | 25,925 | ||
| 2023-03-20 | Paolini John F. CHIEF MEDICAL OFFICER | Option exercise | +3,671 | 41,224 | ||
| 2023-03-20 | Paolini John F. CHIEF MEDICAL OFFICER | Shares withheld for taxes | −1,078 | $11.12 | $12K | 40,146 |
| 2023-03-20 | Paolini John F. CHIEF MEDICAL OFFICER | Option exercise · Restricted Share Unit | −3,671 | 0 | ||
| 2023-03-20 | Moat Ross CHIEF COMMERCIAL OFFICER | Option exercise | +2,137 | 12,596 |
Page 62 of 74 · 1,467 trades